XT
SANA icon

XTX Topco’s Sana Biotechnology SANA Stock Holding History

XTX Topco’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$318K Sell
110,310
-7,066
-6% -$27.8K 0.01% 2439
2025
Q4 		$478K Buy
117,376
+10,581
+10% +$47.4K 0.01% 1641
2025
Q3 		$379K Buy
+106,795
New +$386K 0.02% 1309
2025
Q1 		– Sell
-175,167
Closed -$286K – 3009
2024
Q4 		$286K Buy
+175,167
New +$522K 0.02% 1265
2024
Q3 		– Sell
-18,249
Closed -$99.6K – 2537
2024
Q2 		$99.6K Buy
+18,249
New +$145K 0.01% 1420
2024
Q1 		– Sell
-30,282
Closed -$124K – 2264
2023
Q4 		$124K Buy
+30,282
New +$112K 0.03% 1087
2023
Q3 		– Sell
-10,081
Closed -$60.1K – 1959
2023
Q2 		$60.1K Sell
10,081
-3,137
-24% -$18.1K 0.01% 1220
2023
Q1 		$43.2K Sell
13,218
-71,925
-84% -$287K 0.01% 1182
2022
Q4 		$336K Buy
+85,143
New +$416K 0.07% 515
2022
Q2 		– Sell
-10,406
Closed -$86K – 1072
2022
Q1 		$86K Buy
+10,406
New +$84.1K 0.04% 535

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

XTX Topco's SANA Position: Q1 2026 in Review

XTX Topco reduced its Sana Biotechnology (SANA) stake by 6% in Q1 2026, selling an estimated $27.8K and leaving 110,310 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #2439.

XTX Topco first reported a position in SANA in Q1 2022 and has held it in 10 quarters since. The position peaked at $478K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • XTX Topco held 110,310 shares of Sana Biotechnology worth $318K as of Q1 2026.
  • XTX Topco sold 7,066 Sana Biotechnology shares in Q1 2026, an estimated $27.8K.
  • Sana Biotechnology made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2439 holding.
  • XTX Topco first reported a position in Sana Biotechnology in Q1 2022 and has held it in 10 quarters since.
  • XTX Topco's Sana Biotechnology position peaked at $478K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.